Maynard Um
-
-
-
-
-
-
-
Genmab A/S (GMAB) April 30, 35 and 40 calls active, share price down 2.5%
-
-
-
-
-
-
-
Genmab A/S (GMAB) PT Lowered to $40 at Guggenheim
-
-
-
-
-
-
-
Genmab reports $14.35 billion in DARZALEX sales for 2025
-
-
-
-
-
-
-
Genmab A/S (GMAB) PT Raised to $38 at Leerink Partners
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Genmab A/S (GMAB)
-
-
-
-
-
-
-
Genmab A/S (GMAB) PT Raised to $32 at TD Cowen
-
-
-
-
-
-
-
Genmab A/S (GMAB) Announces Grant of Restricted Stock Units and Warrants to Employees
-
411,276 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

